Exeter Financial LLC Acquires 315 Shares of The Procter & Gamble Company (NYSE:PG)

Exeter Financial LLC increased its holdings in The Procter & Gamble Company (NYSE:PGFree Report) by 2.0% in the 1st quarter, according to its most recent filing with the SEC. The institutional investor owned 16,232 shares of the company’s stock after buying an additional 315 shares during the quarter. Exeter Financial LLC’s holdings in Procter & Gamble were worth $2,523,000 at the end of the most recent reporting period.

Other large investors have also made changes to their positions in the company. HighPoint Advisor Group LLC bought a new stake in shares of Procter & Gamble during the 4th quarter valued at about $17,696,000. Dfpg Investments LLC lifted its holdings in Procter & Gamble by 1.7% in the 4th quarter. Dfpg Investments LLC now owns 24,892 shares of the company’s stock worth $3,680,000 after purchasing an additional 424 shares in the last quarter. Campbell Wealth Management lifted its holdings in Procter & Gamble by 13.1% in the 4th quarter. Campbell Wealth Management now owns 1,988 shares of the company’s stock worth $291,000 after purchasing an additional 231 shares in the last quarter. Herold Advisors Inc. lifted its holdings in Procter & Gamble by 2.2% in the 4th quarter. Herold Advisors Inc. now owns 26,592 shares of the company’s stock worth $3,897,000 after purchasing an additional 581 shares in the last quarter. Finally, Metis Global Partners LLC lifted its holdings in Procter & Gamble by 15.7% in the 4th quarter. Metis Global Partners LLC now owns 115,039 shares of the company’s stock worth $16,858,000 after purchasing an additional 15,599 shares in the last quarter. 65.77% of the stock is currently owned by institutional investors.

Procter & Gamble Stock Down 0.9 %

Shares of PG traded down $1.46 during midday trading on Thursday, reaching $165.99. 1,543,784 shares of the stock were exchanged, compared to its average volume of 6,547,338. The Procter & Gamble Company has a 52 week low of $141.45 and a 52 week high of $169.41. The company has a current ratio of 0.69, a quick ratio of 0.48 and a debt-to-equity ratio of 0.49. The company’s 50 day moving average is $165.28 and its two-hundred day moving average is $158.54. The company has a market capitalization of $391.76 billion, a P/E ratio of 27.31, a PEG ratio of 3.39 and a beta of 0.42.

Procter & Gamble (NYSE:PGGet Free Report) last posted its earnings results on Friday, April 19th. The company reported $1.52 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.42 by $0.10. Procter & Gamble had a return on equity of 33.91% and a net margin of 18.00%. The company had revenue of $20.20 billion for the quarter, compared to analyst estimates of $20.43 billion. During the same quarter in the previous year, the firm earned $1.37 earnings per share. The firm’s quarterly revenue was up .6% compared to the same quarter last year. On average, sell-side analysts anticipate that The Procter & Gamble Company will post 6.55 earnings per share for the current year.

Procter & Gamble Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Wednesday, May 15th. Shareholders of record on Friday, April 19th were paid a $1.0065 dividend. This represents a $4.03 annualized dividend and a yield of 2.43%. The ex-dividend date was Thursday, April 18th. This is a positive change from Procter & Gamble’s previous quarterly dividend of $0.94. Procter & Gamble’s payout ratio is 65.85%.

Insider Buying and Selling at Procter & Gamble

In other Procter & Gamble news, insider Moses Victor Javier Aguilar sold 9,149 shares of Procter & Gamble stock in a transaction dated Thursday, May 16th. The stock was sold at an average price of $167.72, for a total value of $1,534,470.28. Following the transaction, the insider now owns 12,929 shares in the company, valued at $2,168,451.88. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. In other Procter & Gamble news, insider Moses Victor Javier Aguilar sold 9,149 shares of the firm’s stock in a transaction dated Thursday, May 16th. The stock was sold at an average price of $167.72, for a total value of $1,534,470.28. Following the completion of the sale, the insider now owns 12,929 shares of the company’s stock, valued at $2,168,451.88. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. Also, CEO R. Alexandra Keith sold 855 shares of the firm’s stock in a transaction dated Monday, April 22nd. The stock was sold at an average price of $158.50, for a total value of $135,517.50. Following the completion of the sale, the chief executive officer now directly owns 4,004 shares of the company’s stock, valued at approximately $634,634. The disclosure for this sale can be found here. Insiders have sold 154,544 shares of company stock worth $25,413,051 over the last quarter. Insiders own 0.17% of the company’s stock.

Analyst Ratings Changes

A number of research analysts recently commented on the company. Argus boosted their price target on Procter & Gamble from $180.00 to $185.00 and gave the stock a “buy” rating in a report on Thursday, April 25th. Deutsche Bank Aktiengesellschaft decreased their price objective on Procter & Gamble from $172.00 to $171.00 and set a “buy” rating on the stock in a report on Monday, April 22nd. Barclays upped their price objective on Procter & Gamble from $168.00 to $170.00 and gave the stock an “overweight” rating in a report on Tuesday, April 23rd. The Goldman Sachs Group initiated coverage on Procter & Gamble in a report on Friday, March 1st. They set a “neutral” rating and a $168.00 price objective on the stock. Finally, Jefferies Financial Group upped their price objective on Procter & Gamble from $175.00 to $182.00 and gave the stock a “buy” rating in a report on Monday, April 22nd. Six research analysts have rated the stock with a hold rating and fourteen have given a buy rating to the company. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $170.72.

Check Out Our Latest Research Report on PG

About Procter & Gamble

(Free Report)

The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands.

Featured Articles

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Procter & Gamble Company (NYSE:PGFree Report).

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.